Under the radar is definitely one way to put it. How I see it:...

Under the radar is definitely one way to put it.

How I see it:

Many pre-Covid holders bought it a lot higher, and are taking a loss on any decent volume available.

There’s not enough new interest at the moment, but I believe that will drastically change.

-Company is basically at cash backing. No need to raise any time soon.

-Sales are back up, with expansion into new markets on the agenda. Current growth suggests profitability is not far off.

-US military contract due by mid next year (IMO it’s likely as we know the product works, and DoD have already invested significantly)

-Further new product trial results due soon.

With these points in mind I believe buying under 10c is a bargain. Hard to believe it will be below 15c come mid next year.